TipRanks
Advertisement
Advertisement
Apollo Therapeutics Advances Camoteskimab and Expands Genetics-Led Pulmonary Hypertension Focus
PremiumPrivate CompaniesApollo Therapeutics Advances Camoteskimab and Expands Genetics-Led Pulmonary Hypertension Focus
4M ago
Apollo Therapeutics Highlights ZIP12-Targeted Approach in Pulmonary Hypertension R&D
Premium
Private Companies
Apollo Therapeutics Highlights ZIP12-Targeted Approach in Pulmonary Hypertension R&D
4M ago
Apollo Therapeutics Showcases Genetics-Inspired Pulmonary Hypertension Research Focus
Premium
Private Companies
Apollo Therapeutics Showcases Genetics-Inspired Pulmonary Hypertension Research Focus
4M ago
Apollo Therapeutics Showcases Phase 2a Camoteskimab Data in Atopic Dermatitis
PremiumPrivate CompaniesApollo Therapeutics Showcases Phase 2a Camoteskimab Data in Atopic Dermatitis
4M ago
Apollo Therapeutics Highlights Phase 2a Camoteskimab Data in Dermatology Meeting
Premium
Private Companies
Apollo Therapeutics Highlights Phase 2a Camoteskimab Data in Dermatology Meeting
4M ago
Apollo Therapeutics Showcases Genetics-Driven Pulmonary Hypertension Strategy
Premium
Private Companies
Apollo Therapeutics Showcases Genetics-Driven Pulmonary Hypertension Strategy
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100